Page 581 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 25 Tumors of the Skeletal System 559

181. Liptak JM, Kamstock DA, Dernell WS, et al.: Oncologic outcome 202. LaRue SM, Withrow SJ, Powers BE, et al.: Limb-sparing treatment
after curative-intent treatment in 39 dogs with primary chest wall for osteosarcoma in dogs, J Am Vet Med Assoc 195:1734–1744,
tumors (1992-2005), Vet Surg 37:488–496, 2008. 1989.
VetBooks.ir 182. Sternberg RA, Pondenis HC, Yang X, et al.: Association between 203. Thrall DE, Withrow SJ, Powers BE, et al.: Radiotherapy prior to
cortical allograft limb sparing in dogs with osteosarcoma; a dose
absolute tumor burden and serum bone-specific alkaline phospha-
tase in canine appendicular osteosarcoma, J Vet Intern Med 27:955–
response assay, Int J Radiat Oncol Biol Phys 18:1351–1357, 1990.
963, 2013. 204. Vasseur P: Limb preservation in dogs with primary bone tumors,
183. Holmes KE, Thompson V, Piskun CM, et al.: Canine osteosar- Vet Clin North Am Small Anim Pract 17:889–903, 1987.
coma cell lines from patients with differing serum alkaline phos- 205. Withrow SJ, Thrall DE, Straw RC, et al.: Intra-arterial cisplatin
phatase concentrations display no behavioural differences in vitro, with or without radiation in limb-sparing for canine osteosarcoma,
Vet Comp Oncol 13:166–175, 2015. Cancer 71:2484–2490, 1993.
184. McCleese JK, Bear MD, Kulp SK, et al.: Met interacts with EGFR 206. Straw RC, Withrow SJ: Limb-sparing surgery versus amputation
and Ron in canine osteosarcoma, Vet Comp Oncol 11:124–139, for dogs with bone tumors, Vet Clin North Am Small Anim Pract
2013. 26:135–143, 1996.
185. Mullins MN, Lana SE, Dernell WS, et al.: Cyclooxygenase-2 207. O’Brien MG, Straw RC, Withrow SJ, et al.: Resection of pulmo-
expression in canine appendicular osteosarcomas, J Vet Intern Med nary metastases in canine osteosarcoma; 36 cases (1983-1992), Vet
18:859–865, 2004. Surg 22:105–109, 1993.
186. Shoeneman JK, Ehrhart 3rd EJ, Eickhoff JC, et al.: Expression and 208. Selmic LE, Burton JH, Thamm DH, et al.: Comparison of carbo-
function of survivin in canine osteosarcoma, Cancer Res 72:249– platin and doxorubicin-based chemotherapy protocols in 470 dogs
259, 2012. after amputation for treatment of appendicular osteosarcoma, J Vet
187. Thamm DH, O’Brien MG, Vail DM: Serum vascular endothelial Intern Med 28:554–563, 2014.
growth factor concentrations and postsurgical outcome in dogs 209. Liptak JM, Dernell WS, Straw RC, et al.: Intercalary bone grafts
with osteosarcoma, Vet Comp Oncol 6:126–132, 2008. for joint and limb preservation in 17 dogs with high-grade malig-
188. Selvarajah GT, Bonestroo FA, Kirpensteijn J, et al.: Heat shock nant tumors of the diaphysis, Vet Surg 33:457–467, 2004.
protein expression analysis in canine osteosarcoma reveals HSP60 210. Morello E, Buracco P, Martano M, et al.: Bone allografts and adju-
as a potentially relevant therapeutic target, Cell Stress Chaperones vant cisplatin for the treatment of canine appendicular osteosar-
18:607–622, 2013. coma in 18 dogs, J Small Anim Pract 42:61–66, 2001.
189. Millanta F, Asproni P, Cancedda S, et al.: Immunohistochemical 211. Tomford WW, Doppelt SH, Mankin HJ, et al.: 1983 bone bank
expression of COX-2, mPGES and EP2 receptor in normal and procedures, Clin Orthop Relat R15–21, 1983.
reactive canine bone and in canine osteosarcoma, J Comp Pathol 212. Straw RC, Powers BE, Withrow SJ, et al.: The effect of intramed-
147:153–160, 2012. ullary polymethylmethacrylate on healing of intercalary cortical
190. Pang LY, Gatenby EL, Kamida A, et al.: Global gene expression allografts in a canine model, J Orthopaed Res 10:434–439, 1992.
analysis of canine osteosarcoma stem cells reveals a novel role for 213. Kirpensteijn J, Steinheimer D, Park RD, et al.: Comparison of
COX-2 in tumour initiation, PLoS One 9:e83144, 2014. cemented and non-cemented allografts in dogs with osteosarcoma,
191. Selvarajah GT, Kirpensteijn J, van Wolferen ME, et al.: Gene Vet Comp Orthopaed 11:178–184, 1998.
expression profiling of canine osteosarcoma reveals genes associated 214. Liptak JM, Dernell WS, Ehrhart N, et al.: Cortical allograft and
with short and long survival times, Mol Cancer 8:72, 2009. endoprosthesis for limb-sparing surgery in dogs with distal radial
192. Scott MC, Sarver AL, Gavin KJ, et al.: Molecular subtypes of osteo- osteosarcoma; a prospective clinical comparison of two different
sarcoma identified by reducing tumor heterogeneity through an limb-sparing techniques, Vet Surg 35:518–533, 2006.
interspecies comparative approach, Bone 49:356–367, 2011. 215. Mitchell KE, Boston SE, Kung M, et al.: Outcomes of limb-sparing
193. Biller BJ, Elmslie RE, Burnett RC, et al.: Use of FoxP3 expression surgery using two generations of metal endoprosthesis in 45 dogs
to identify regulatory T cells in healthy dogs and dogs with cancer, with distal radial osteosarcoma. A Veterinary Society of Surgical
Vet Immunol Immunopathol 116:69–78, 2007. Oncology retrospective study, Vet Surg 45:36–43, 2016.
194. O’Neill K, Guth A, Biller B, et al.: Changes in regulatory T cells in 216. Bray JP, Kersley A, Downing W, et al.: Clinical outcomes of
dogs with cancer and associations with tumor type, J Vet Intern Med patient-specific porous titanium endoprostheses in dogs with
23:875–881, 2009. tumors of the mandible, radius, or tibia; 12 cases (2013-2016),
195. Rissetto KC, Rindt H, Selting KA, et al.: Cloning and expression of J Am Vet Med Assoc 251:566–579, 2017.
canine CD25 for validation of an anti-human CD25 antibody to 217. Fitzpatrick N, Guthrie JW: Hemipelvic and proximal femoral limb
compare T regulatory lymphocytes in healthy dogs and dogs with salvage endoprosthesis with tendon ongrowth in a dog, Vet Surg
osteosarcoma, Vet Immunol Immunopathol 135:137–145, 2010. 47:963–969, 2018.
196. Biller BJ, Guth A, Burton JH, et al.: Decreased ratio of CD8+ T 218. Degna MT, Ehrhart N, Feretti A, et al.: Bone transport osteogen-
cells to regulatory T cells associated with decreased survival in dogs esis for limb salvage - Following resection of primary bone tumors;
with osteosarcoma, J Vet Intern Med 24:1118–1123, 2010. experience with six cases (1991-1996), Vet Comp Orthopaed 13:18–
197. Tuohy JL, Lascelles BD, Griffith EH, et al.: Association of canine 22, 2000.
osteosarcoma and monocyte phenotype and chemotactic function, 219. Ehrhart N: Longitudinal bone transport for treatment of primary
J Vet Intern Med 30:1167–1178, 2016. bone tumors in dogs; technique description and outcome in 9 dogs,
198. Withers SS, Skorupski KA, York D, et al.: Association of macro- Vet Surg 34:24–34, 2005.
phage and lymphocyte infiltration with outcome in canine osteo- 220. Jehn CT, Lewis DD, Farese JP, et al.: Transverse ulnar bone trans-
sarcoma, Vet Comp Oncol, 2018. epub ahead of print. port osteogenesis;a new technique for limb salvage for the treat-
199. Withrow SJ, Hirsch VM: Owner response to amputation of a pet’s ment of distal radial osteosarcoma in dogs, Vet Surg 36:324–334,
leg, Vet Med Small Anim Clin 74(332):334, 1979. 2007.
200. Carberry CA, Harvey HJ: Owner satisfaction with limb amputa- 221. Ehrhart N, Eurell JA, Tommasini M, et al.: Effect of cisplatin on
tion in dogs and cats, J Am Anim Hosp Assoc 23:227–232, 1987. bone transport osteogenesis in dogs, Am J Vet Res 63:703–711,
201. Berg J, Weinstein MJ, Schelling SH, et al.: Treatment of dogs with 2002.
osteosarcoma by administration of cisplatin after amputation or 222. Rovesti GL, Bascucci M, Schmidt K, et al.: Limb sparing using
limb-sparing surgery; 22 cases (1987-1990), J Am Vet Med Assoc a double bone-transport technique for treatment of a distal tibial
200:2005–2008, 1992. osteosarcoma in a dog, Vet Surg 31:70–77, 2002.